As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit https://cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at https://www.opm.gov.

Gemtuzumab Ozogamicin

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (gem-TOO-zoo-mab OH-zoh-ga-MIH-sin )

This page contains brief information about gemtuzumab ozogamicin and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Mylotarg
FDA Approved
Yes

FDA Approval for Gemtuzumab Ozogamicin

Use in Cancer

Gemtuzumab ozogamicin is approved to treat:

Gemtuzumab ozogamicin is also being studied in the treatment of other types of cancer.

More About Gemtuzumab Ozogamicin

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Gemtuzumab Receives New FDA Approval for Acute Myeloid Leukemia

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Gemtuzumab Ozogamicin - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: January 25, 2007
  • Updated: September 29, 2017